The bed nucleus of the stria terminalis regulates ethanol-seeking behavior in mice

Melanie M. Pina, Emily A. Young, Andrey Ryabinin, Christopher Cunningham

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Drug-associated stimuli are considered important factors in relapse to drug use. In the absence of drug, these cues can trigger drug craving and drive subsequent drug seeking. One structure that has been implicated in this process is the bed nucleus of the stria terminalis (BNST), a chief component of the extended amygdala. Previous studies have established a role for the BNST in cue-induced cocaine seeking. However, it is unclear if the BNST underlies cue-induced seeking of other abused drugs such as ethanol. In the present set of experiments, BNST involvement in ethanol-seeking behavior was assessed in male DBA/2J mice using the conditioned place preference procedure (CPP). The BNST was inhibited during CPP expression using electrolytic lesions (Experiment 1), co-infusion of GABAA and GABAB receptor agonists muscimol and baclofen (M + B; Experiment 2), and activation of inhibitory designer receptors exclusively activated by designer drugs (hM4Di-DREADD) with clozapine-N-oxide (CNO; Experiment 3). The magnitude of ethanol CPP was reduced significantly by each of these techniques. Notably, infusion of M + B (Exp. 2) abolished CPP altogether. Follow-up studies to Exp. 3 showed that ethanol cue-induced c-Fos immunoreactivity in the BNST was reduced by hM4Di activation (Experiment 4) and in the absence of hM4Di, CNO did not affect ethanol CPP (Experiment 5). Combined, these findings demonstrate that the BNST is involved in the modulation of cue-induced ethanol-seeking behavior.

Original languageEnglish (US)
Pages (from-to)627-638
Number of pages12
JournalNeuropharmacology
Volume99
DOIs
StatePublished - Dec 9 2015

Fingerprint

Septal Nuclei
Ethanol
Cues
Pharmaceutical Preparations
Designer Drugs
GABA-A Receptor Agonists
Muscimol
Inbred DBA Mouse
Baclofen
Amygdala
Cocaine
Recurrence

Keywords

  • Alcohol
  • Amygdala
  • Bed nucleus of the stria terminalis (BNST)
  • c-Fos
  • Chemogenetic
  • Clozapine-N-oxide (CNO)
  • CPP
  • DBA/2J
  • dBNST
  • DREADD
  • Ethanol
  • hM4Di
  • Inactivation
  • Lesion
  • Microinfusion
  • Microinjection
  • Place preference
  • RASSL
  • vBNST

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

The bed nucleus of the stria terminalis regulates ethanol-seeking behavior in mice. / Pina, Melanie M.; Young, Emily A.; Ryabinin, Andrey; Cunningham, Christopher.

In: Neuropharmacology, Vol. 99, 09.12.2015, p. 627-638.

Research output: Contribution to journalArticle

@article{b18643bd22fc41bbbe753f1102e6797c,
title = "The bed nucleus of the stria terminalis regulates ethanol-seeking behavior in mice",
abstract = "Drug-associated stimuli are considered important factors in relapse to drug use. In the absence of drug, these cues can trigger drug craving and drive subsequent drug seeking. One structure that has been implicated in this process is the bed nucleus of the stria terminalis (BNST), a chief component of the extended amygdala. Previous studies have established a role for the BNST in cue-induced cocaine seeking. However, it is unclear if the BNST underlies cue-induced seeking of other abused drugs such as ethanol. In the present set of experiments, BNST involvement in ethanol-seeking behavior was assessed in male DBA/2J mice using the conditioned place preference procedure (CPP). The BNST was inhibited during CPP expression using electrolytic lesions (Experiment 1), co-infusion of GABAA and GABAB receptor agonists muscimol and baclofen (M + B; Experiment 2), and activation of inhibitory designer receptors exclusively activated by designer drugs (hM4Di-DREADD) with clozapine-N-oxide (CNO; Experiment 3). The magnitude of ethanol CPP was reduced significantly by each of these techniques. Notably, infusion of M + B (Exp. 2) abolished CPP altogether. Follow-up studies to Exp. 3 showed that ethanol cue-induced c-Fos immunoreactivity in the BNST was reduced by hM4Di activation (Experiment 4) and in the absence of hM4Di, CNO did not affect ethanol CPP (Experiment 5). Combined, these findings demonstrate that the BNST is involved in the modulation of cue-induced ethanol-seeking behavior.",
keywords = "Alcohol, Amygdala, Bed nucleus of the stria terminalis (BNST), c-Fos, Chemogenetic, Clozapine-N-oxide (CNO), CPP, DBA/2J, dBNST, DREADD, Ethanol, hM4Di, Inactivation, Lesion, Microinfusion, Microinjection, Place preference, RASSL, vBNST",
author = "Pina, {Melanie M.} and Young, {Emily A.} and Andrey Ryabinin and Christopher Cunningham",
year = "2015",
month = "12",
day = "9",
doi = "10.1016/j.neuropharm.2015.08.033",
language = "English (US)",
volume = "99",
pages = "627--638",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The bed nucleus of the stria terminalis regulates ethanol-seeking behavior in mice

AU - Pina, Melanie M.

AU - Young, Emily A.

AU - Ryabinin, Andrey

AU - Cunningham, Christopher

PY - 2015/12/9

Y1 - 2015/12/9

N2 - Drug-associated stimuli are considered important factors in relapse to drug use. In the absence of drug, these cues can trigger drug craving and drive subsequent drug seeking. One structure that has been implicated in this process is the bed nucleus of the stria terminalis (BNST), a chief component of the extended amygdala. Previous studies have established a role for the BNST in cue-induced cocaine seeking. However, it is unclear if the BNST underlies cue-induced seeking of other abused drugs such as ethanol. In the present set of experiments, BNST involvement in ethanol-seeking behavior was assessed in male DBA/2J mice using the conditioned place preference procedure (CPP). The BNST was inhibited during CPP expression using electrolytic lesions (Experiment 1), co-infusion of GABAA and GABAB receptor agonists muscimol and baclofen (M + B; Experiment 2), and activation of inhibitory designer receptors exclusively activated by designer drugs (hM4Di-DREADD) with clozapine-N-oxide (CNO; Experiment 3). The magnitude of ethanol CPP was reduced significantly by each of these techniques. Notably, infusion of M + B (Exp. 2) abolished CPP altogether. Follow-up studies to Exp. 3 showed that ethanol cue-induced c-Fos immunoreactivity in the BNST was reduced by hM4Di activation (Experiment 4) and in the absence of hM4Di, CNO did not affect ethanol CPP (Experiment 5). Combined, these findings demonstrate that the BNST is involved in the modulation of cue-induced ethanol-seeking behavior.

AB - Drug-associated stimuli are considered important factors in relapse to drug use. In the absence of drug, these cues can trigger drug craving and drive subsequent drug seeking. One structure that has been implicated in this process is the bed nucleus of the stria terminalis (BNST), a chief component of the extended amygdala. Previous studies have established a role for the BNST in cue-induced cocaine seeking. However, it is unclear if the BNST underlies cue-induced seeking of other abused drugs such as ethanol. In the present set of experiments, BNST involvement in ethanol-seeking behavior was assessed in male DBA/2J mice using the conditioned place preference procedure (CPP). The BNST was inhibited during CPP expression using electrolytic lesions (Experiment 1), co-infusion of GABAA and GABAB receptor agonists muscimol and baclofen (M + B; Experiment 2), and activation of inhibitory designer receptors exclusively activated by designer drugs (hM4Di-DREADD) with clozapine-N-oxide (CNO; Experiment 3). The magnitude of ethanol CPP was reduced significantly by each of these techniques. Notably, infusion of M + B (Exp. 2) abolished CPP altogether. Follow-up studies to Exp. 3 showed that ethanol cue-induced c-Fos immunoreactivity in the BNST was reduced by hM4Di activation (Experiment 4) and in the absence of hM4Di, CNO did not affect ethanol CPP (Experiment 5). Combined, these findings demonstrate that the BNST is involved in the modulation of cue-induced ethanol-seeking behavior.

KW - Alcohol

KW - Amygdala

KW - Bed nucleus of the stria terminalis (BNST)

KW - c-Fos

KW - Chemogenetic

KW - Clozapine-N-oxide (CNO)

KW - CPP

KW - DBA/2J

KW - dBNST

KW - DREADD

KW - Ethanol

KW - hM4Di

KW - Inactivation

KW - Lesion

KW - Microinfusion

KW - Microinjection

KW - Place preference

KW - RASSL

KW - vBNST

UR - http://www.scopus.com/inward/record.url?scp=84941268283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941268283&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2015.08.033

DO - 10.1016/j.neuropharm.2015.08.033

M3 - Article

VL - 99

SP - 627

EP - 638

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -